153 related articles for article (PubMed ID: 21601849)
21. The role of inositol supplementation in patients with polycystic ovary syndrome, with insulin resistance, undergoing the low-dose gonadotropin ovulation induction regimen.
Cittadini E
Fertil Steril; 2011 Jun; 95(8):e57; author reply e58. PubMed ID: 21514580
[No Abstract] [Full Text] [Related]
22. Evaluation of the relationship between follicular fluid oxidative stress, ovarian hormones, and response to gonadotropin stimulation.
Appasamy M; Jauniaux E; Serhal P; Al-Qahtani A; Groome NP; Muttukrishna S
Fertil Steril; 2008 Apr; 89(4):912-21. PubMed ID: 17681319
[TBL] [Abstract][Full Text] [Related]
23. The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis.
Bosdou JK; Venetis CA; Kolibianakis EM; Toulis KA; Goulis DG; Zepiridis L; Tarlatzis BC
Hum Reprod Update; 2012; 18(2):127-45. PubMed ID: 22307331
[TBL] [Abstract][Full Text] [Related]
24. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
[TBL] [Abstract][Full Text] [Related]
25. Androgen supplementation in IVF.
Kim CH
Minerva Ginecol; 2013 Oct; 65(5):497-504. PubMed ID: 24096287
[TBL] [Abstract][Full Text] [Related]
26. GnRH antagonist rescue of a long-protocol IVF cycle and GnRH agonist trigger to avoid ovarian hyperstimulation syndrome: three case reports.
Martínez F; Rodríguez DB; Buxaderas R; Tur R; Mancini F; Coroleu B
Fertil Steril; 2011 Jun; 95(7):2432.e17-9. PubMed ID: 21513932
[TBL] [Abstract][Full Text] [Related]
27. Repeated in vitro fertilization cycle attempts in patients undergoing controlled ovarian hyperstimulation with use of gonadotropin-releasing hormone antagonists.
Rabinson J; Ashkenazi J; Homburg R; Meltcer S; Anteby EY; Orvieto R
Fertil Steril; 2009 Apr; 91(4 Suppl):1473-5. PubMed ID: 18937940
[TBL] [Abstract][Full Text] [Related]
28. In vitro maturation of germinal vesicle oocytes recovered after premature luteinizing hormone surge: description of a novel approach to fertility preservation.
Oktay K; Demirtas E; Son WY; Lostritto K; Chian RC; Tan SL
Fertil Steril; 2008 Jan; 89(1):228.e19-22. PubMed ID: 17517403
[TBL] [Abstract][Full Text] [Related]
29. Modified natural-cycle in vitro fertilization should be considered as the first approach in young poor responders.
Kadoch IJ; Phillips SJ; Bissonnette F
Fertil Steril; 2011 Nov; 96(5):1066-8. PubMed ID: 22036050
[TBL] [Abstract][Full Text] [Related]
30. Middle cerebral artery thrombosis after IVF and ovarian hyperstimulation: a case report.
Jing Z; Yanping L
Fertil Steril; 2011 Jun; 95(7):2435.e13-5. PubMed ID: 21601668
[TBL] [Abstract][Full Text] [Related]
31. Luteal phase estradiol versus luteal phase estradiol and antagonist protocol for controlled ovarian stimulation before in vitro fertilization in poor responders.
Elassar A; Mann JS; Engmann L; Nulsen J; Benadiva C
Fertil Steril; 2011 Jan; 95(1):324-6. PubMed ID: 20797708
[TBL] [Abstract][Full Text] [Related]
32. Clinical and endocrine response to the withdrawal of gonadotropin-releasing hormone agonists during prolonged coasting.
Ho Yuen B; Nguyen TA; Cheung AP; Leung PC
Fertil Steril; 2009 Aug; 92(2):499-507. PubMed ID: 18706551
[TBL] [Abstract][Full Text] [Related]
33. Human menopausal gonadotropin versus highly purified-hMG in controlled ovarian hyperstimulation for in-vitro fertilisation: does purity improve outcome?
Orvieto R; Meltcer S; Liberty G; Rabinson J; Anteby EY; Nahum R
Gynecol Endocrinol; 2010 Oct; 26(10):733-5. PubMed ID: 20500109
[TBL] [Abstract][Full Text] [Related]
34. A luteal estradiol protocol for anticipated poor-responder patients may improve delivery rates.
Hill MJ; McWilliams GD; Miller KA; Scott RT; Frattarelli JL
Fertil Steril; 2009 Mar; 91(3):739-43. PubMed ID: 18314123
[TBL] [Abstract][Full Text] [Related]
35. Degrees of uncertainty--"statistically insignificant".
Claman P
Fertil Steril; 2008 Oct; 90(4):1331; author reply 1331. PubMed ID: 18793767
[No Abstract] [Full Text] [Related]
36. Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques.
Cheon KW; Byun HK; Yang KM; Song IO; Choi KH; Yoo KJ
J Reprod Med; 2004 Sep; 49(9):733-8. PubMed ID: 15493565
[TBL] [Abstract][Full Text] [Related]
37. A combined approach to patients with repeated IVF failures.
Orvieto R; Meltcer S; Liberty G; Rabinson J; Anteby EY; Nahum R
Fertil Steril; 2010 Nov; 94(6):2462-4. PubMed ID: 20451192
[TBL] [Abstract][Full Text] [Related]
38. GnRH agonist versus GnRH antagonist in ovarian stimulation: the influence of body mass index on in vitro fertilization outcome.
Rabinson J; Meltcer S; Zohav E; Gemer O; Anteby EY; Orvieto R
Fertil Steril; 2008 Feb; 89(2):472-4. PubMed ID: 17582402
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic value of progesterone level and progesterone/estradiol ratio on the day of human chorionic gonadotropin administration.
Guijarro Ponce JA; Núñez Calonge R
Fertil Steril; 2011 Aug; 96(2):e137; author reply e138. PubMed ID: 21700281
[No Abstract] [Full Text] [Related]
40. A randomised controlled trial of 300 versus 225 IU recombinant FSH for ovarian stimulation in predicted normal responders by antral follicle count.
Jayaprakasan K; Hopkisson J; Campbell B; Johnson I; Thornton J; Raine-Fenning N
BJOG; 2010 Jun; 117(7):853-62. PubMed ID: 20353458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
